PQ 712
712. Deputy Brian Leddin asked the Minister for Health when the HSE executive management team will reconsider supporting the reimbursement of dupilumab dupixent for the treatment of moderate to severe atopic dermatitis in adults and adolescents of 12 years of age and older that are candidates for systemic therapy; and if he will make a statement on the matter. [24801/20]
Introduced
22 September 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 September 2020
Summary
712. Deputy Brian Leddin asked the Minister for Health when the HSE executive management team will reconsider supporting the reimbursement of dupilumab dupixent for the treatment of moderate to severe atopic dermatitis in adults and adolescents of 12 years of age and older that are candidates for systemic therapy; and if he will make a statement on the matter. [24801/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 22 September 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-09-22/712/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-09-22/pq_712